Expanding access to novel treatment and care for acute myeloid leukemia (AML)

Acute myeloid leukemia (AML) is a type of cancer that forms in blood cells and bone marrow that progresses rapidly if untreated. In this presentation, Dr. Brett Houston, a hematologist at the University of Manitoba, will speak about her work in clinical trials in finding ways to optimize care and improve outcomes for patients affected with acute leukemia, as well as expanding access to novel therapeutics for these blood cancers.